Skip to main content
Top
Published in: Inflammation 5/2021

01-10-2021 | Rhinosinusitis | Original Article

Mucus composition abnormalities in sinonasal mucosa of chronic rhinosinusitis with and without nasal polyps

Authors: Yanyi Tu, Jing Liu, Tao Li, Xiangmin Zhou, Kai Sen Tan, Hsiao Hui Ong, Kaiyue Sun, Yi Ouyang, Xu Liang, Yew Kwang Ong, Mark Thong, Li Shi, De-Yun Wang

Published in: Inflammation | Issue 5/2021

Login to get access

Abstract

Mucus secretion and its composition are vital in the maintenance of airway health, among which hypoxia-inducible factors (HIFs) are thought to be involved in the regulation of mucin synthesis and regulation. Nasal mucus composition difference between healthy individuals and chronic rhinosinusitis (CRS) patients may contribute to the pathology of chronic nasal diseases, but so far, their role has yet to be completely understood. Nasal biopsy specimens were obtained from 24 healthy subjects and 99 patients with CRS without (CRSsNP, n=36) or with (CRSwNP, n=63) nasal polyps. Immunohistochemical (IHC) and immunofluorescent (IF) staining, quantitative real-time PCR, and western blot were performed to compare the nasal mucus composition between the subjects. Areas of the serous gland and mucous gland were both significantly increased in CRSsNP patients. In CRSwNP patients, a decrease in submucosal gland density and a marked increase in goblet cells were observed. The major gel-forming mucins in the sinonasal mucosa of CRSsNP and CRSwNP are MUC5B and MUC5AC respectively. Mucous cells are found in a higher proportion in both CRSsNP and CRSwNP. The proportion of MUC5AC-positive goblet cells was increased in CRSwNP. The mRNA level of HIF-2α was significantly increased in CRS, and both HIF-1α and HIF-2α were expressed in serous cell but not mucous cell. Over secretion and altered composition of mucus are observed in sinonasal mucosa of CRS, which was mainly associated with glandular hyperplasia in CRSsNP and goblet cell hyperplasia in CRSwNP. Mucus abnormality compromised both non-specific and specific antimicrobial capabilities in the sinonasal mucosa. HIF expression may contribute to differences in mucin synthesis and serous gland regulation, which needs further investigation to understand the pathology of CRS.
Literature
1.
go back to reference Kaliner, M., Z. Marom, C. Patow, and J. Shelhamer. 1984. Human respiratory mucus. The Journal of Allergy and Clinical Immunology 73: 318–323.PubMedCrossRef Kaliner, M., Z. Marom, C. Patow, and J. Shelhamer. 1984. Human respiratory mucus. The Journal of Allergy and Clinical Immunology 73: 318–323.PubMedCrossRef
2.
go back to reference Lee, R.J., and J.K. Foskett. 2010. Mechanisms of Ca2+-stimulated fluid secretion by porcine bronchial submucosal gland serous acinar cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: L210–L231.PubMedCrossRef Lee, R.J., and J.K. Foskett. 2010. Mechanisms of Ca2+-stimulated fluid secretion by porcine bronchial submucosal gland serous acinar cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: L210–L231.PubMedCrossRef
3.
go back to reference May, A.J., T.H.N. Teshima, A. Noble, and A.S. Tucker. 2019. FGF10 is an essential regulator of tracheal submucosal gland morphogenesis. Developmental Biology 451: 158–166.PubMedCrossRef May, A.J., T.H.N. Teshima, A. Noble, and A.S. Tucker. 2019. FGF10 is an essential regulator of tracheal submucosal gland morphogenesis. Developmental Biology 451: 158–166.PubMedCrossRef
4.
go back to reference Raphael, G.D., E.V. Jeney, J.N. Baraniuk, I. Kim, S.D. Meredith, and M.A. Kaliner. 1989. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. The Journal of Clinical Investigation 84: 1528–1535.PubMedPubMedCentralCrossRef Raphael, G.D., E.V. Jeney, J.N. Baraniuk, I. Kim, S.D. Meredith, and M.A. Kaliner. 1989. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. The Journal of Clinical Investigation 84: 1528–1535.PubMedPubMedCentralCrossRef
5.
go back to reference Finkbeiner, W.E. 1999. Physiology and pathology of tracheobronchial glands. Respiration Physiology 118: 77–83.PubMedCrossRef Finkbeiner, W.E. 1999. Physiology and pathology of tracheobronchial glands. Respiration Physiology 118: 77–83.PubMedCrossRef
6.
go back to reference Lundgren, J.D., and J.H. Shelhamer. 1990. Pathogenesis of airway mucus hypersecretion. The Journal of Allergy and Clinical Immunology 85: 399–417.PubMedCrossRef Lundgren, J.D., and J.H. Shelhamer. 1990. Pathogenesis of airway mucus hypersecretion. The Journal of Allergy and Clinical Immunology 85: 399–417.PubMedCrossRef
7.
go back to reference Schraven, S.P., M. Wehrmann, W. Wagner, G. Blumenstock, and A. Koitschev. 2011. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. Journal of Cystic Fibrosis 10: 181–186.PubMedCrossRef Schraven, S.P., M. Wehrmann, W. Wagner, G. Blumenstock, and A. Koitschev. 2011. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. Journal of Cystic Fibrosis 10: 181–186.PubMedCrossRef
8.
go back to reference Wu, X., M.M. Amorn, P.K. Aujla, S. Rice, R. Mimms, A.M. Watson, J.R. Peters-Hall, M.C. Rose, and M.T. Peña. 2011. Histologic characteristics and mucin immunohistochemistry of cystic fibrosis sinus mucosa. Archives of Otolaryngology – Head & Neck Surgery 137: 383–389.CrossRef Wu, X., M.M. Amorn, P.K. Aujla, S. Rice, R. Mimms, A.M. Watson, J.R. Peters-Hall, M.C. Rose, and M.T. Peña. 2011. Histologic characteristics and mucin immunohistochemistry of cystic fibrosis sinus mucosa. Archives of Otolaryngology – Head & Neck Surgery 137: 383–389.CrossRef
9.
go back to reference Fokkens, W.J., V.J. Lund, C. Hopkins, P.W. Hellings, R. Kern, S. Reitsma, et al. 2020. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58: 1–464.PubMedCrossRef Fokkens, W.J., V.J. Lund, C. Hopkins, P.W. Hellings, R. Kern, S. Reitsma, et al. 2020. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58: 1–464.PubMedCrossRef
10.
go back to reference Van Bruaene, N., and C. Bachert. 2011. Tissue remodeling in chronic rhinosinusitis. Current Opinion in Allergy and Clinical Immunology 11: 8–11.PubMedCrossRef Van Bruaene, N., and C. Bachert. 2011. Tissue remodeling in chronic rhinosinusitis. Current Opinion in Allergy and Clinical Immunology 11: 8–11.PubMedCrossRef
11.
go back to reference Cummins, E.P., E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, F. Seeballuck, C. Godson, J.E. Nielsen, P. Moynagh, J. Pouyssegur, and C.T. Taylor. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proceedings of the National Academy of Sciences of the United States of America 103: 18154–18159.PubMedPubMedCentralCrossRef Cummins, E.P., E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, F. Seeballuck, C. Godson, J.E. Nielsen, P. Moynagh, J. Pouyssegur, and C.T. Taylor. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proceedings of the National Academy of Sciences of the United States of America 103: 18154–18159.PubMedPubMedCentralCrossRef
12.
go back to reference Kaelin, W.G., Jr., and P.J. Ratcliffe. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell 30: 393–402.PubMedCrossRef Kaelin, W.G., Jr., and P.J. Ratcliffe. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell 30: 393–402.PubMedCrossRef
13.
go back to reference Khalmuratova, R., M. Lee, J.H. Mo, Y. Jung, J.W. Park, and H.W. Shin. 2018. Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1alpha and survivin suppression. Scientific Reports 8: 6201.PubMedPubMedCentralCrossRef Khalmuratova, R., M. Lee, J.H. Mo, Y. Jung, J.W. Park, and H.W. Shin. 2018. Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1alpha and survivin suppression. Scientific Reports 8: 6201.PubMedPubMedCentralCrossRef
14.
go back to reference Shin, H.W., K. Cho, D.W. Kim, D.H. Han, R. Khalmuratova, S.W. Kim, S.Y. Jeon, Y.G. Min, C.H. Lee, C.S. Rhee, and J.W. Park. 2012. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. American Journal of Respiratory and Critical Care Medicine 185: 944–954.PubMedCrossRef Shin, H.W., K. Cho, D.W. Kim, D.H. Han, R. Khalmuratova, S.W. Kim, S.Y. Jeon, Y.G. Min, C.H. Lee, C.S. Rhee, and J.W. Park. 2012. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. American Journal of Respiratory and Critical Care Medicine 185: 944–954.PubMedCrossRef
15.
go back to reference Lee, M., D.W. Kim, H. Yoon, D. So, R. Khalmuratova, C.S. Rhee, et al. 2016. Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition. The Journal of Allergy and Clinical Immunology 137: 87–98 e7.PubMedCrossRef Lee, M., D.W. Kim, H. Yoon, D. So, R. Khalmuratova, C.S. Rhee, et al. 2016. Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition. The Journal of Allergy and Clinical Immunology 137: 87–98 e7.PubMedCrossRef
16.
go back to reference Song, G., J. Kim, F.W. Bazer, and T.E. Spencer. 2008. Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus. Endocrinology 149: 1926–1934.PubMedPubMedCentralCrossRef Song, G., J. Kim, F.W. Bazer, and T.E. Spencer. 2008. Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus. Endocrinology 149: 1926–1934.PubMedPubMedCentralCrossRef
17.
go back to reference Terrizzi, A.R., M.I. Conti, M.P. Martinez, and J. Fernandez-Solari. 2018. The process of acclimation to chronic hypoxia leads to submandibular gland and periodontal alterations: an insight on the role of inflammatory mediators. Mediators of Inflammation 2018: 6794508.PubMedPubMedCentralCrossRef Terrizzi, A.R., M.I. Conti, M.P. Martinez, and J. Fernandez-Solari. 2018. The process of acclimation to chronic hypoxia leads to submandibular gland and periodontal alterations: an insight on the role of inflammatory mediators. Mediators of Inflammation 2018: 6794508.PubMedPubMedCentralCrossRef
18.
go back to reference Leopold, D.A., D. Elkayam, J.C. Messina, C. Kosik-Gonzalez, P.G. Djupesland, and R.A. Mahmoud. 2019. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. The Journal of Allergy and Clinical Immunology 143: 126–34 e5.PubMedCrossRef Leopold, D.A., D. Elkayam, J.C. Messina, C. Kosik-Gonzalez, P.G. Djupesland, and R.A. Mahmoud. 2019. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. The Journal of Allergy and Clinical Immunology 143: 126–34 e5.PubMedCrossRef
19.
go back to reference Lildholdt, T., H. Rundcrantz, and N. Lindqvist. 1995. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clinical Otolaryngology and Allied Sciences 20: 26–30.PubMedCrossRef Lildholdt, T., H. Rundcrantz, and N. Lindqvist. 1995. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clinical Otolaryngology and Allied Sciences 20: 26–30.PubMedCrossRef
20.
go back to reference Payne, S.C., S.B. Early, P. Huyett, J.K. Han, L. Borish, and J.W. Steinke. 2011. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope 121: 2262–2267.PubMedPubMedCentralCrossRef Payne, S.C., S.B. Early, P. Huyett, J.K. Han, L. Borish, and J.W. Steinke. 2011. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope 121: 2262–2267.PubMedPubMedCentralCrossRef
21.
go back to reference Kiwamoto, T., T. Katoh, C.M. Evans, W.J. Janssen, M.E. Brummet, S.A. Hudson, et al. 2015. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. The Journal of Allergy and Clinical Immunology 135: 1329–40 e9.PubMedCrossRef Kiwamoto, T., T. Katoh, C.M. Evans, W.J. Janssen, M.E. Brummet, S.A. Hudson, et al. 2015. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. The Journal of Allergy and Clinical Immunology 135: 1329–40 e9.PubMedCrossRef
22.
go back to reference Berger, G., T. Kogan, D. Ophir, E. Skutelsky, and K. Pitaro. 2008. Glycoconjugate expression of sinus mucosa in chronic rhinosinusitis: a lectin histochemical study. American Journal of Rhinology 22: 349–355.PubMedCrossRef Berger, G., T. Kogan, D. Ophir, E. Skutelsky, and K. Pitaro. 2008. Glycoconjugate expression of sinus mucosa in chronic rhinosinusitis: a lectin histochemical study. American Journal of Rhinology 22: 349–355.PubMedCrossRef
23.
go back to reference Burgel, P.R., E. Escudier, A. Coste, T. Dao-Pick, I.F. Ueki, K. Takeyama, J.J. Shim, A.H. Murr, and J.A. Nadel. 2000. Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. The Journal of Allergy and Clinical Immunology 106: 705–712.PubMedCrossRef Burgel, P.R., E. Escudier, A. Coste, T. Dao-Pick, I.F. Ueki, K. Takeyama, J.J. Shim, A.H. Murr, and J.A. Nadel. 2000. Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. The Journal of Allergy and Clinical Immunology 106: 705–712.PubMedCrossRef
24.
go back to reference Liu, J., Y.Y. Li, A.K. Andiappan, Y. Yan, K.S. Tan, H.H. Ong, K.T. Thong, Y.K. Ong, F.G. Yu, H.B. Low, Y.L. Zhang, L. Shi, and D.Y. Wang. 2018. Role of IL-13Ralpha2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa. Allergy 73: 1673–1685.PubMedCrossRef Liu, J., Y.Y. Li, A.K. Andiappan, Y. Yan, K.S. Tan, H.H. Ong, K.T. Thong, Y.K. Ong, F.G. Yu, H.B. Low, Y.L. Zhang, L. Shi, and D.Y. Wang. 2018. Role of IL-13Ralpha2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa. Allergy 73: 1673–1685.PubMedCrossRef
25.
go back to reference Kirkham, S., J.K. Sheehan, D. Knight, P.S. Richardson, and D.J. Thornton. 2002. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochemical Journal 361: 537–546.PubMedCentralCrossRefPubMed Kirkham, S., J.K. Sheehan, D. Knight, P.S. Richardson, and D.J. Thornton. 2002. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochemical Journal 361: 537–546.PubMedCentralCrossRefPubMed
26.
go back to reference Zhao, J., B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, H. Hu, J.B. Trudeau, V. O'Donnell, and S.E. Wenzel. 2009. Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. American Journal of Respiratory and Critical Care Medicine 179: 782–790.PubMedPubMedCentralCrossRef Zhao, J., B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, H. Hu, J.B. Trudeau, V. O'Donnell, and S.E. Wenzel. 2009. Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. American Journal of Respiratory and Critical Care Medicine 179: 782–790.PubMedPubMedCentralCrossRef
27.
go back to reference Mansson, A., M. Adner, U. Hockerfelt, and L.O. Cardell. 2006. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 118: 539–548.PubMedPubMedCentral Mansson, A., M. Adner, U. Hockerfelt, and L.O. Cardell. 2006. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 118: 539–548.PubMedPubMedCentral
28.
go back to reference Rousseau, K., C. Wickstrom, D.B. Whitehouse, I. Carlstedt, and D.M. Swallow. 2003. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybridoma and Hybridomics 22: 293–299.PubMedCrossRef Rousseau, K., C. Wickstrom, D.B. Whitehouse, I. Carlstedt, and D.M. Swallow. 2003. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybridoma and Hybridomics 22: 293–299.PubMedCrossRef
29.
go back to reference Ramsey KA, Rushton ZL, Ehre C (2016) Mucin agarose gel electrophoresis: western blotting for high-molecular-weight glycoproteins. Journal of Visualized Experiments 112: e54153. Ramsey KA, Rushton ZL, Ehre C (2016) Mucin agarose gel electrophoresis: western blotting for high-molecular-weight glycoproteins. Journal of Visualized Experiments 112: e54153.
30.
go back to reference Basbaum, C.B., B. Jany, and W.E. Finkbeiner. 1990. The serous cell. Annual Review of Physiology 52: 97–113.PubMedCrossRef Basbaum, C.B., B. Jany, and W.E. Finkbeiner. 1990. The serous cell. Annual Review of Physiology 52: 97–113.PubMedCrossRef
31.
go back to reference Jolles, P., and J. Jolles. 1984. What's new in lysozyme research? Always a model system, today as yesterday. Molecular and Cellular Biochemistry 63: 165–189.PubMedCrossRef Jolles, P., and J. Jolles. 1984. What's new in lysozyme research? Always a model system, today as yesterday. Molecular and Cellular Biochemistry 63: 165–189.PubMedCrossRef
32.
go back to reference Woods, C.M., V.S. Lee, D.J. Hussey, S. Irandoust, E.H. Ooi, L.W. Tan, and A.S. Carney. 2012. Lysozyme expression is increased in the sinus mucosa of patients with chronic rhinosinusitis. Rhinology 50: 147–156.PubMedCrossRef Woods, C.M., V.S. Lee, D.J. Hussey, S. Irandoust, E.H. Ooi, L.W. Tan, and A.S. Carney. 2012. Lysozyme expression is increased in the sinus mucosa of patients with chronic rhinosinusitis. Rhinology 50: 147–156.PubMedCrossRef
33.
go back to reference De Rose, V., K. Molloy, S. Gohy, C. Pilette, and C.M. Greene. 2018. Airway epithelium dysfunction in cystic fibrosis and COPD. Mediators of Inflammation 2018: 1309746.PubMedPubMedCentral De Rose, V., K. Molloy, S. Gohy, C. Pilette, and C.M. Greene. 2018. Airway epithelium dysfunction in cystic fibrosis and COPD. Mediators of Inflammation 2018: 1309746.PubMedPubMedCentral
34.
go back to reference Land, L.M., P. Li, and P.M. Bummer. 2005. The influence of water content of triglyceride oils on the solubility of steroids. Pharmaceutical Research 22: 784–788.PubMedCrossRef Land, L.M., P. Li, and P.M. Bummer. 2005. The influence of water content of triglyceride oils on the solubility of steroids. Pharmaceutical Research 22: 784–788.PubMedCrossRef
35.
go back to reference Van Crombruggen, K., N. Zhang, P. Gevaert, P. Tomassen, and C. Bachert. 2011. Pathogenesis of chronic rhinosinusitis: inflammation. The Journal of Allergy and Clinical Immunology 128: 728–732.PubMedCrossRef Van Crombruggen, K., N. Zhang, P. Gevaert, P. Tomassen, and C. Bachert. 2011. Pathogenesis of chronic rhinosinusitis: inflammation. The Journal of Allergy and Clinical Immunology 128: 728–732.PubMedCrossRef
36.
go back to reference Fitzpatrick, S.F., M.M. Tambuwala, U. Bruning, B. Schaible, C.C. Scholz, A. Byrne, A. O’Connor, W.M. Gallagher, C.R. Lenihan, J.F. Garvey, K. Howell, P.G. Fallon, E.P. Cummins, and C.T. Taylor. 2011. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. Journal of Immunology 186: 1091–1096.CrossRef Fitzpatrick, S.F., M.M. Tambuwala, U. Bruning, B. Schaible, C.C. Scholz, A. Byrne, A. O’Connor, W.M. Gallagher, C.R. Lenihan, J.F. Garvey, K. Howell, P.G. Fallon, E.P. Cummins, and C.T. Taylor. 2011. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. Journal of Immunology 186: 1091–1096.CrossRef
37.
go back to reference Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, R.S. Johnson, G.G. Haddad, and M. Karin. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807–811.PubMedPubMedCentralCrossRef Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, R.S. Johnson, G.G. Haddad, and M. Karin. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807–811.PubMedPubMedCentralCrossRef
38.
go back to reference Murdoch, C., A. Giannoudis, and C.E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224–2234.PubMedCrossRef Murdoch, C., A. Giannoudis, and C.E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224–2234.PubMedCrossRef
39.
go back to reference Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E.A. Theodorakis, R.L. Gallo, N. Hurtado-Ziola, V. Nizet, and R.S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. The Journal of Clinical Investigation 115: 1806–1815.PubMedPubMedCentralCrossRef Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E.A. Theodorakis, R.L. Gallo, N. Hurtado-Ziola, V. Nizet, and R.S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. The Journal of Clinical Investigation 115: 1806–1815.PubMedPubMedCentralCrossRef
40.
go back to reference Polosukhin, V.V., J.M. Cates, W.E. Lawson, A.P. Milstone, A.G. Matafonov, P.P. Massion, J.W. Lee, S.H. Randell, and T.S. Blackwell. 2011. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. The Journal of Pathology 224: 203–211.PubMedCrossRef Polosukhin, V.V., J.M. Cates, W.E. Lawson, A.P. Milstone, A.G. Matafonov, P.P. Massion, J.W. Lee, S.H. Randell, and T.S. Blackwell. 2011. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. The Journal of Pathology 224: 203–211.PubMedCrossRef
41.
go back to reference Zhou, X., J. Tu, Q. Li, V.P. Kolosov, and J.M. Perelman. 2012. Hypoxia induces mucin expression and secretion in human bronchial epithelial cells. Translational Research 160: 419–427.PubMedCrossRef Zhou, X., J. Tu, Q. Li, V.P. Kolosov, and J.M. Perelman. 2012. Hypoxia induces mucin expression and secretion in human bronchial epithelial cells. Translational Research 160: 419–427.PubMedCrossRef
42.
go back to reference Yu, H., Q. Li, V.P. Kolosov, J.M. Perelman, and X. Zhou. 2012. Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1alpha via epidermal growth factor receptor-mediated signaling pathways. Journal of Applied Toxicology 32: 282–292.PubMedCrossRef Yu, H., Q. Li, V.P. Kolosov, J.M. Perelman, and X. Zhou. 2012. Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1alpha via epidermal growth factor receptor-mediated signaling pathways. Journal of Applied Toxicology 32: 282–292.PubMedCrossRef
Metadata
Title
Mucus composition abnormalities in sinonasal mucosa of chronic rhinosinusitis with and without nasal polyps
Authors
Yanyi Tu
Jing Liu
Tao Li
Xiangmin Zhou
Kai Sen Tan
Hsiao Hui Ong
Kaiyue Sun
Yi Ouyang
Xu Liang
Yew Kwang Ong
Mark Thong
Li Shi
De-Yun Wang
Publication date
01-10-2021
Publisher
Springer US
Keyword
Rhinosinusitis
Published in
Inflammation / Issue 5/2021
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01471-6

Other articles of this Issue 5/2021

Inflammation 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine